IBM Marketscan
LizzyN edited this page Feb 19, 2022
·
1 revision
MarketScan Research Databases is a group of longitudinal databases of privately and publicly insured, de-identified patient data in the United States. These data reflect the real world of treatment patterns and costs by tracking millions of patients even as they switch health plans.
These individual-level healthcare claims data include carve-out services, clinical utilization, expenditures, insurance enrollment/plan benefit for inpatient, outpatient, and prescription drugs for a large population of individuals and their dependents with employer-provided commercial insurance in the United States.
- Standard demographic variables - patient age, gender, and race.
- Inpatient data.
- Outpatient services and prescription drug claims.
- Information about long-term care and other medical care.
- Data on eligibility (by month).
- Service and provider types are also included.
- MarketScan databases are based on a large convenience sample. The sample is not random and may contain biases or fail to generalize well to other populations.
- Data come primarily from large employers. So, although this database includes a large amount of data contributed from health plans, small and medium firms may be underrepresented.
- Accessing the data requires data management software or programmer support.
- Truven Health Analytics MarketScan Databases for Clinical Research in Colon and Rectal Surgery
- The economic burden of metastatic pancreatic cancer
- The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases
- Prescription opioid fills following surgical abortion
- Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab
- Fair regression for health care spending
- Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data
- Hydroxychloroquine early in pregnancy and risk of birth defects
- Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
- Predictors of Receiving Keratoplasty for Keratoconus